Cantex to Expand Development of Its Drug, Azeliragon, Collaborating with Harvard's Wyss Institute, as a Treatment of COVID-19 and Other Inflammatory Lung Diseases
WESTON, Fla., Feb. 24, 2022 /PRNewswire/ -- Cantex Pharmaceuticals, Inc., a clinical-stage pharmaceutical company based in Weston, FL, announced that it has secured a global licens…
